Lustri and colleagues119 evaluated two TGF‐β1 inhibitors in primary human mucin‐ and mixed‐intrahepatic CCA cell cultures, finding that one reduced cell viability and induced apoptosis, while the other impaired cell migration. This evidence concerns the gene TGFB1 and cholangiocarcinoma.